CDIOW — Cardio Diagnostics Holdings, Inc.

Nasdaq · Health Care · Life Sciences Tools & Services · CIK 1870144 ·
Last close
Market Cap
52W High
52W Low
ADV30
Next earnings
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, such as concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 2,680 -1,784,837 -1,788,158 9,559,371 7,077,021 655,972
Dec 2025 3,555 -1,463,222 -1,465,368 7,766,415 5,110,630 793,061
Sep 2025 2,855 -1,711,597 -1,714,536 8,788,902 6,355,218 637,331
Jun 2025 7,475 -1,678,699 -1,683,199 10,396,547 7,966,500 671,848

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-5,726,833
Investing CF
$-419,310
Financing CF
$3,429,286
CapEx
$-419,310
Dividends Paid
Buybacks
EPS Diluted TTM
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-29,250,000
Inventory
Receivables
$8,126
ST Investments
EBIT TTM
$-6,483,366
Pretax Income TTM
$-6,498,167
Interest Exp TTM
$14,801
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$16,565
EBITDA
$-6,270,895
Free Cash Flow
$-3,927,246
Enterprise Value
Total Cash
$7,077,021
Total Debt
$533,002
Shares Out
Trailing EPS
Book Value
$3.01
ROE
-65.6%
ROA
-38.0%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 14,825 -6,484,078 -6,498,167 7,766,415 793,061 -5,726,833
Dec 2024 34,890 -8,365,877 -8,383,453 10,615,312 1,057,524 -4,993,104
Dec 2023 17,065 -7,242,459 -8,376,834 4,462,365 1,504,241 -5,672,175
Dec 2022 950 -4,548,451 -4,660,985 6,249,478 1,947,770 -5,090,968

Peers — same industry

TickerNameMarket CapLastDaily %
IDXX IDEXX LABORATORIES INC /DE $43.95B $557.21
IQV IQVIA HOLDINGS INC. $27.04B $162.00
INCY INCYTE CORP $19.40B $97.10
MEDP Medpace Holdings, Inc. $12.26B $429.11
ICLR ICON PLC $8.69B $113.85

News headlines (Yahoo Finance, 1h cache)

Cardio Diagnostics Holdings (CDIO) CEO Highlights Growth Strategy, India Expansion on BioMedWire Podcast
2026-05-20 19:00 · Yahoo
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Meesha Dogan, CEO of Cardio Diagnostics Holdings Inc.
2026-05-20 12:00 · Yahoo
Cardio Diagnostics Holdings (CDIO) Focused on Vision for Personalized Heart Care
2026-05-19 19:35 · Yahoo
Cardio Diagnostics Holdings (CDIO) Offers Broad Suite of AI-Powered Solutions for Cardiovascular Disease Prevention
2026-05-19 17:47 · Yahoo
Cardio Diagnostics Holdings (CDIO) Advancing Early Detection, Tackling Heart Disease Through AI and Biomarker Insights
2026-05-01 19:00 · Yahoo
Cardio Diagnostics Holdings (CDIO) Advancing AI Solutions for Cardiovascular Disease Detection and Management
2026-04-27 18:28 · Yahoo
Why Cardio Diagnostics Holdings (CDIO) is 'One to Watch'
2026-04-20 18:45 · Yahoo
IBN Initiates Coverage of Cardio Diagnostics Holdings Inc.
2026-04-08 12:30 · Yahoo
Cardio Diagnostics Holdings (CDIO) Is 'One to Watch'
2026-04-01 19:30 · Yahoo
CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, February 19, 2026
2026-02-18 16:17 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.